These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 12648417)

  • 1. [Therapeutic effect of alpha 1b interferon on patients with chronic hepatitis B: changes in serological fibrosis markers and histology].
    Zhang HY; Lu H; Li XM; Duan HY
    Zhonghua Gan Zang Bing Za Zhi; 2003 Feb; 11(2):117-8. PubMed ID: 12648417
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum markers and pathological evaluation in hepatitis fibrosis of chronic hepatitis B treated with interferon alpha].
    Deng L; Zhou Y; Peng X; Deng H; Deng Y; Yao J
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jul; 9 Suppl():66-7. PubMed ID: 11509145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of interferon alpha on the serum fibrosis markers of chronic hepatitis C patients].
    Zhang BB; Zhu SH; Cai WM
    Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):622-3. PubMed ID: 14572344
    [No Abstract]   [Full Text] [Related]  

  • 4. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
    Park JH; Park CK; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The evaluation of hyaluronic acid and laminin concentration in serum in children with chronic hepatitis B treated with lamivudine, unresponsive to previous interferon-alpha therapy].
    Skiba E; Lebensztejn DM; Werpachowska I; Kaczmarski M
    Pol Merkur Lekarski; 2005 Mar; 18(105):268-70. PubMed ID: 15997629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The predictive value of liver fibrosis in determining the effectiveness of interferon and lamivudine therapies for chronic hepatitis B.
    Shindo M; Hamada K; Nishioji K; Muramatsu A; Oda Y; Okuno T
    J Gastroenterol; 2004; 39(3):260-7. PubMed ID: 15065004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-fibrosis effect of IFN-gamma and IFN-alpha on chronic hepatitis B patients].
    Li XH; Wang CG; Pan XN; Li YX; Zhuang YP
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):243. PubMed ID: 12716531
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.
    van Zonneveld M; Honkoop P; Hansen BE; Niesters HG; Darwish Murad S; de Man RA; Schalm SW; Janssen HL
    Hepatology; 2004 Mar; 39(3):804-10. PubMed ID: 14999700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of antiviral treatment on intrahepatic HBV DNA and histology in HBeAg -positive chronic hepatitis B patients].
    Lu HY; Zhuang LW; Yu YY; Si CW; Zheng JJ; Chen XY; Han ZH; Chen Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Feb; 22(1):54-6. PubMed ID: 18414702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation between liver fibrosis stage and serum liver fibrosis markers in patients with chronic hepatitis B].
    Ding H; Chen Y; Feng X; Liu D; Wu A; Zhang L
    Zhonghua Gan Zang Bing Za Zhi; 2001 Apr; 9(2):78-80. PubMed ID: 11350682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between HBV genotypes and anti-viral therapeutic efficacy of interferon-alpha.
    Ma JC; Wang LW; Li XJ; Liao YF; Hu XY; Gong ZJ
    Hepatobiliary Pancreat Dis Int; 2007 Apr; 6(2):166-71. PubMed ID: 17374576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive diagnostic screening of hepatic fibrosis in patients with chronic hepatitis B.
    Chen YP; Feng XR; Dai L; Zhang L; Hou JL
    Chin Med J (Engl); 2004 Jul; 117(7):1109-12. PubMed ID: 15265393
    [No Abstract]   [Full Text] [Related]  

  • 13. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
    Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC
    Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative HBV DNA levels as an early predictor of nonresponse in chronic HBe-antigen positive hepatitis B patients treated with interferon-alpha.
    van der Eijk AA; Niesters HG; Hansen BE; Heijtink RA; Janssen HL; Schalm SW; de Man RA
    J Viral Hepat; 2006 Feb; 13(2):96-103. PubMed ID: 16436127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-lamivudine combination is no better than lamivudine alone in anti-HBe-positive chronic hepatitis B.
    Akarca US; Ersoz G; Gunsar F; Karasu Z; Saritas E; Yuce G; Batur Y
    Antivir Ther; 2004 Jun; 9(3):325-34. PubMed ID: 15259895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of simultaneous determination of serum hyaluronic acid, collagen type IV and the laminin level in diagnosing liver fibrosis].
    Liang XH; Zheng H
    Hunan Yi Ke Da Xue Xue Bao; 2002 Feb; 27(1):67-8. PubMed ID: 12575242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to interferon-alpha in chronic hepatitis B patients with and without precore mutant strain and effects on HBsAg titers.
    Akhan SC; Yulugkural Z; Vahaboglu H
    Chemotherapy; 2007; 53(6):402-6. PubMed ID: 17934260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A clinical study of consensus interferon alpha treatment in chronic hepatitis B virus-infected patients].
    Yan T; Wang HF; Li K; Zhang AM
    Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):314-5. PubMed ID: 17456329
    [No Abstract]   [Full Text] [Related]  

  • 19. Persistence of HBV-DNA in children with chronic hepatitis B who seroconverted to anti-HBs antibodies after interferon-alpha therapy: correlation with specific IgG subclass responses to HBsAg.
    Gregorek H; Dzierzanowska-Fangrat K; Woynarowski M; Jóźwiak P; Witkowska-Vogtt E; Socha J; Syczewska M; Madaliński K
    J Hepatol; 2005 Apr; 42(4):486-90. PubMed ID: 15763334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individualization of interferon therapy using serum hepatitis B virus DNA to reduce viral relapse in patients with chronic hepatitis B: a randomized controlled trial.
    Chung YH; Song BC; Lee GC; Shin JW; Ryu SH; Jung SA; Yoo K; Lee HC; Lee YS; Suh DJ
    Eur J Gastroenterol Hepatol; 2003 May; 15(5):489-93. PubMed ID: 12702905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.